Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma. [electronic resource]
Producer: 20180223Description: 770-777 p. digitalISSN:- 1534-4681
- Adenocarcinoma -- genetics
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Disease-Free Survival
- ErbB Receptors -- genetics
- Female
- Humans
- Immunohistochemistry
- Lung Neoplasms -- genetics
- Male
- Middle Aged
- Mutation
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Pneumonectomy
- Proto-Oncogene Proteins c-met -- metabolism
- Retrospective Studies
- Survival Rate
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.